Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Frequency and characteristics of short versus longitudinally extensive myelitis in adults with MOG antibodies: A retrospective multicentric study.

Ciron J, Cobo-Calvo A, Audoin B, Bourre B, Brassat D, Cohen M, Collongues N, Deschamps R, Durand-Dubief F, Laplaud D, Maillart E, Papeix C, Zephir H, Bereau M, Brochet B, Carra-Dallière C, Derache N, Gagou-Scherer C, Henry C, Kerschen P, Mathey G, Maubeuge N, Maurousset A, Montcuquet A, Moreau T, Prat C, Taithe F, Thouvenot E, Tourbah A, Rollot F, Vukusic S, Marignier R.

Mult Scler. 2019 May 31:1352458519849511. doi: 10.1177/1352458519849511. [Epub ahead of print]

PMID:
31148523
2.

Miller Fisher syndrome mimicking botulism: Clinical and pathophysiological discussion of a case.

Bigaut K, Kremer L, Hacquard A, Collongues N, De Seze J.

Rev Neurol (Paris). 2019 Apr 29. pii: S0035-3787(18)30407-7. doi: 10.1016/j.neurol.2018.06.012. [Epub ahead of print] No abstract available.

PMID:
31047688
3.

Pathologic and MRI analysis in acute atypical inflammatory demyelinating lesions.

Ayrignac X, Rigau V, Lhermitte B, Vincent T, de Champfleur NM, Carra-Dalliere C, Charif M, Collongues N, de Seze J, Hebbadj S, Ahle G, Oesterlé H, Cotton F, Durand-Dubief F, Marignier R, Vukusic S, Taithe F, Cohen M, Guennoc AM, Kerbrat A, Edan G, Carsin-Nicol B, Allou T, Sablot D, Thouvenot E, Ruet A, Magy L, Boncoeur-Martel MP, Labauge P, Kremer S.

J Neurol. 2019 Apr 23. doi: 10.1007/s00415-019-09328-7. [Epub ahead of print]

PMID:
31016376
4.

A case of acute posterior multifocal placoid pigment epitheliopathy with aseptic meningitis and cerebral infarction.

Bigaut K, Kremer L, Hacquard A, Wolff B, Collongues N, De Seze J.

Rev Neurol (Paris). 2019 May;175(5):329-331. doi: 10.1016/j.neurol.2018.06.011. Epub 2019 Mar 28. No abstract available.

PMID:
30928157
5.

Correction to: Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adults.

Cobo-Calvo A, Sepúlveda M, d'Indy H, Armangué T, Ruiz A, Maillart E, Papeix C, Audoin B, Zephir H, Biotti D, Ciron J, Durand-Dubief F, Collongues N, Ayrignac X, Labauge P, Thouvenot E, Montcuquet A, Deschamps R, Solà-Valls N, Llufriu S, Blanco Y, de Seze J, Vukusic S, Saiz A, Marignier R; OFSEP Group; REEM Group.

J Neurol. 2019 Apr;266(4):816. doi: 10.1007/s00415-019-09215-1.

PMID:
30759286
6.

Resting-state functional MRI demonstrates brain network reorganization in neuromyelitis optica spectrum disorder (NMOSD).

Bigaut K, Achard S, Hemmert C, Baloglu S, Kremer L, Collongues N, De Sèze J, Kremer S.

PLoS One. 2019 Jan 29;14(1):e0211465. doi: 10.1371/journal.pone.0211465. eCollection 2019.

7.

Pharmacotherapy for Neuromyelitis Optica Spectrum Disorders: Current Management and Future Options.

Collongues N, Ayme-Dietrich E, Monassier L, de Seze J.

Drugs. 2019 Feb;79(2):125-142. doi: 10.1007/s40265-018-1039-7. Review.

PMID:
30623348
8.

Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adults.

Cobo-Calvo A, Sepúlveda M, d'Indy H, Armangué T, Ruiz A, Maillart E, Papeix C, Audoin B, Zephir H, Biotti D, Ciron J, Durand-Dubief F, Collongues N, Ayrignac X, Labauge P, Thouvenot E, Montcuquet A, Deschamps R, Solà-Valls N, Llufriu S, Blanco Y, de Seze J, Vukusic S, Saiz A, Marignier R; OFSEP Group; REEM Group.

J Neurol. 2019 Apr;266(4):806-815. doi: 10.1007/s00415-018-9160-9. Epub 2019 Jan 3. Erratum in: J Neurol. 2019 Feb 7;:.

PMID:
30607536
9.

Multiple sclerosis with atypical MRI presentation: Results of a nationwide multicenter study in 57 consecutive cases.

Codjia P, Ayrignac X, Carra-Dalliere C, Cohen M, Charif M, Lippi A, Collongues N, Corti L, De Seze J, Lebrun C, Vukusic S, Durand-Dubief F, Labauge P; SFSEP and OFSEP.

Mult Scler Relat Disord. 2019 Feb;28:109-116. doi: 10.1016/j.msard.2018.12.022. Epub 2018 Dec 18.

PMID:
30592992
10.

Ocrelizumab for the treatment of multiple sclerosis.

Bigaut K, De Seze J, Collongues N.

Expert Rev Neurother. 2019 Feb;19(2):97-108. doi: 10.1080/14737175.2019.1561284. Epub 2018 Dec 28.

PMID:
30570368
11.

Measurement of magnetization transfer ratio (MTR) from cervical spinal cord: Multicenter reproducibility and variability.

Combès B, Monteau L, Bannier E, Callot V, Labauge P, Ayrignac X, Carra Dallière C, Pelletier J, Maarouf A, de Seze J, Collongues N, Barillot C, Edan G, Ferré JC, Kerbrat A; EMISEP study group.

J Magn Reson Imaging. 2019 Jun;49(6):1777-1785. doi: 10.1002/jmri.26537. Epub 2018 Oct 22.

PMID:
30350328
12.

Focal and diffuse cervical spinal cord damage in patients with early relapsing-remitting MS: A multicentre magnetisation transfer ratio study.

Combès B, Kerbrat A, Ferré JC, Callot V, Maranzano J, Badji A, Le Page E, Labauge P, Ayrignac X, Carra Dallière C, de Champfleur NM, Pelletier J, Maarouf A, de Seze J, Collongues N, Brassat D, Durand-Dubief F, Barillot C, Bannier E, Edan G.

Mult Scler. 2019 Jul;25(8):1113-1123. doi: 10.1177/1352458518781999. Epub 2018 Jun 18.

PMID:
29909771
13.

Testosterone and estrogen in multiple sclerosis: from pathophysiology to therapeutics.

Collongues N, Patte-Mensah C, De Seze J, Mensah-Nyagan AG, Derfuss T.

Expert Rev Neurother. 2018 Jun;18(6):515-522. doi: 10.1080/14737175.2018.1481390. Epub 2018 Jun 6. Review.

PMID:
29799288
14.

Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study.

Cobo-Calvo A, Ruiz A, Maillart E, Audoin B, Zephir H, Bourre B, Ciron J, Collongues N, Brassat D, Cotton F, Papeix C, Durand-Dubief F, Laplaud D, Deschamps R, Cohen M, Biotti D, Ayrignac X, Tilikete C, Thouvenot E, Brochet B, Dulau C, Moreau T, Tourbah A, Lebranchu P, Michel L, Lebrun-Frenay C, Montcuquet A, Mathey G, Debouverie M, Pelletier J, Labauge P, Derache N, Coustans M, Rollot F, De Seze J, Vukusic S, Marignier R; OFSEP and NOMADMUS Study Group.

Neurology. 2018 May 22;90(21):e1858-e1869. doi: 10.1212/WNL.0000000000005560. Epub 2018 Apr 25.

PMID:
29695592
15.

Neuromyelitis optica spectrum disorders: Features of aquaporin-4, myelin oligodendrocyte glycoprotein and double-seronegative-mediated subtypes.

Alves Do Rego C, Collongues N.

Rev Neurol (Paris). 2018 Jun;174(6):458-470. doi: 10.1016/j.neurol.2018.02.084. Review.

PMID:
29685427
16.

Recommendations for the use of Rituximab in neuromyelitis optica spectrum disorders

Ciron J, Audoin B, Bourre B, Brassat D, Durand-Dubief F, Laplaud D, Maillart E, Papeix C, Vukusic S, Zephir H, Marignier R, Collongues N; NOMADMUS group, under the aegis of OFSEP, SFSEP.

Rev Neurol (Paris). 2018 Apr;174(4):255-264. doi: 10.1016/j.neurol.2017.11.005. Epub 2018 Mar 30. Review.

PMID:
29606320
17.

Quantitative and qualitative normative dataset for intraepidermal nerve fibers using skin biopsy.

Collongues N, Samama B, Schmidt-Mutter C, Chamard-Witkowski L, Debouverie M, Chanson JB, Antal MC, Benardais K, de Seze J, Velten M, Boehm N.

PLoS One. 2018 Jan 25;13(1):e0191614. doi: 10.1371/journal.pone.0191614. eCollection 2018.

18.

Treating asymptomatic bacteriuria before immunosuppressive therapy during multiple sclerosis: Should we do it?

Rouzaud C, Hautecoeur P, Donze C, Heinzlef O, Dinh A; Club Francophone de la Sclérose en Plaque, Creange A, Abdullatif A, Audouin B, Tourbah A, Berger E, Bourre B, Brochet B, Mekies C, Cabre P, Papeix C, Casez O, Brassat D, Defer G, Derache N, De Seze J, Dive D, LePage E, Fromont A, Gouider R, Edan G, Pelletier J, Grimaud J, Guennoc AM, Camdessanché JP, Kwiatkowski A, Laplaud D, Lebrun C, Debouverie M, Coustans M, Gout O, La Rochelle OA, Heinzlef O, Ouallet JC, Cavelou P, Hautecoeur P, Labauge P, Vermersch P, Wiertlewski S, Vukusic S, Marignier R, Schluep M, Seeldrayers P, Slassi I, Stankoff B, Thaite F, Moreau T, Thouvenot E, Zephir H, Ciron J, Collongues N, Kerschen P, Cohen M, Gueguen A, Mathey G, Carra C, Bernady P, Faucheux JM, Planque E, Donze C, Ruet A, Mouzawakh C, Pittion S.

Mult Scler Relat Disord. 2017 Nov;18:161-163. doi: 10.1016/j.msard.2017.08.009. Epub 2017 Aug 24. No abstract available.

PMID:
29141801
19.

The translocator protein ligand XBD173 improves clinical symptoms and neuropathological markers in the SJL/J mouse model of multiple sclerosis.

Leva G, Klein C, Benyounes J, Hallé F, Bihel F, Collongues N, De Seze J, Mensah-Nyagan AG, Patte-Mensah C.

Biochim Biophys Acta Mol Basis Dis. 2017 Dec;1863(12):3016-3027. doi: 10.1016/j.bbadis.2017.09.007. Epub 2017 Sep 9.

20.

Multiple sclerosis broke my heart.

Androdias G, Bernard E, Biotti D, Collongues N, Durand-Dubief F, Pique J, Sanchez I, Delmas C, Ninet J, Marignier R, Vukusic S.

Ann Neurol. 2017 May;81(5):754-758. doi: 10.1002/ana.24935. Epub 2017 May 9.

PMID:
28437859
21.

Biotherapy in Inflammatory Diseases of the CNS: Current Knowledge and Applications.

Collongues N, Michel L, de Seze J.

Curr Treat Options Neurol. 2017 May;19(5):19. doi: 10.1007/s11940-017-0456-3. Review.

PMID:
28417344
22.

Double-Blind Controlled Randomized Trial of Cyclophosphamide versus Methylprednisolone in Secondary Progressive Multiple Sclerosis.

Brochet B, Deloire MS, Perez P, Loock T, Baschet L, Debouverie M, Pittion S, Ouallet JC, Clavelou P, de Sèze J, Collongues N, Vermersch P, Zéphir H, Castelnovo G, Labauge P, Lebrun C, Cohen M, Ruet A; PROMESS study investigators.

PLoS One. 2017 Jan 3;12(1):e0168834. doi: 10.1371/journal.pone.0168834. eCollection 2017.

23.

Effectiveness of mycophenolate mofetil as first-line therapy in AQP4-IgG, MOG-IgG, and seronegative neuromyelitis optica spectrum disorders.

Montcuquet A, Collongues N, Papeix C, Zephir H, Audoin B, Laplaud D, Bourre B, Brochet B, Camdessanche JP, Labauge P, Moreau T, Brassat D, Stankoff B, de Seze J, Vukusic S, Marignier R; NOMADMUS study group and the Observatoire Français de la Sclérose en Plaques (OFSEP).

Mult Scler. 2017 Sep;23(10):1377-1384. doi: 10.1177/1352458516678474. Epub 2016 Nov 25.

PMID:
27885065
24.

Neuromyelitis optica spectrum disorders in children and adolescents.

Tenembaum S, Chitnis T, Nakashima I, Collongues N, McKeon A, Levy M, Rostasy K.

Neurology. 2016 Aug 30;87(9 Suppl 2):S59-66. doi: 10.1212/WNL.0000000000002824. Review.

PMID:
27572863
25.

Exploratory Phase II Trial to Evaluate the Safety and the Antiepileptic Effect of Pitolisant (BF2.649) in Refractory Partial Seizures, Given as Adjunctive Treatment During 3 Months.

Collart Dutilleul P, Ryvlin P, Kahane P, Vercueil L, Semah F, Biraben A, Schwartz JC, De Seze J, Hirsch E, Collongues N.

Clin Neuropharmacol. 2016 Jul-Aug;39(4):188-93. doi: 10.1097/WNF.0000000000000159.

PMID:
27223666
26.

Neuromyelitis optica spectrum disorder (NMOSD): A new concept.

de Sèze J, Kremer L, Collongues N.

Rev Neurol (Paris). 2016 Apr-May;172(4-5):256-62. doi: 10.1016/j.neurol.2016.03.003. Epub 2016 May 4. Review.

PMID:
27157418
27.

An update on the evidence for the efficacy and safety of rituximab in the management of neuromyelitis optica.

Collongues N, de Seze J.

Ther Adv Neurol Disord. 2016 May;9(3):180-8. doi: 10.1177/1756285616632653. Epub 2016 Mar 23. Review.

28.

Efficacy of rituximab in refractory neuromyelitis optica.

Collongues N, Brassat D, Maillart E, Labauge P, Ouallet JC, Carra-Dalliere C, Moreau T, Bourre B, Papeix C, Brochet B, Audoin B, Vukusic S, de Seze J, Marignier R; OFSEP and CFSEP.

Mult Scler. 2016 Jun;22(7):955-9. doi: 10.1177/1352458515602337. Epub 2015 Sep 11.

PMID:
26362900
29.

Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype.

Pröbstel AK, Rudolf G, Dornmair K, Collongues N, Chanson JB, Sanderson NS, Lindberg RL, Kappos L, de Seze J, Derfuss T.

J Neuroinflammation. 2015 Mar 8;12:46. doi: 10.1186/s12974-015-0256-1.

30.

[Unilateral mydriasis in Lyme neuroborreliosis].

Felten R, Benoilid A, Alves Do Rego C, Collongues N, De Seze J.

Rev Neurol (Paris). 2015 May;171(5):451-2. doi: 10.1016/j.neurol.2015.01.568. Epub 2015 Apr 6. French. No abstract available.

PMID:
25857457
31.

Dalfampridine in hereditary spastic paraplegia: a prospective, open study.

Béreau M, Anheim M, Chanson JB, Tio G, Echaniz-Laguna A, Depienne C, Collongues N, de Sèze J.

J Neurol. 2015 May;262(5):1285-8. doi: 10.1007/s00415-015-7707-6. Epub 2015 Mar 26.

PMID:
25808501
32.

Tear analysis as a tool to detect oligoclonal bands in radiologically isolated syndrome.

Lebrun C, Forzy G, Collongues N, Cohen M, de Seze J, Hautecoeur P; Club francophone de la SEP and RISConsortium.

Rev Neurol (Paris). 2015 Apr;171(4):390-3. doi: 10.1016/j.neurol.2014.11.007. Epub 2015 Jan 19.

PMID:
25613196
33.

Adult-onset genetic leukoencephalopathies: a MRI pattern-based approach in a comprehensive study of 154 patients.

Ayrignac X, Carra-Dalliere C, Menjot de Champfleur N, Denier C, Aubourg P, Bellesme C, Castelnovo G, Pelletier J, Audoin B, Kaphan E, de Seze J, Collongues N, Blanc F, Chanson JB, Magnin E, Berger E, Vukusic S, Durand-Dubief F, Camdessanche JP, Cohen M, Lebrun-Frenay C, Brassat D, Clanet M, Vermersch P, Zephir H, Outteryck O, Wiertlewski S, Laplaud DA, Ouallet JC, Brochet B, Goizet C, Debouverie M, Pittion S, Edan G, Deburghgraeve V, Le Page E, Verny C, Amati-Bonneau P, Bonneau D, Hannequin D, Guyant-Maréchal L, Derache N, Defer GL, Moreau T, Giroud M, Guennoc AM, Clavelou P, Taithe F, Mathis S, Neau JP, Magy L, Devoize JL, Bataillard M, Masliah-Planchon J, Dorboz I, Tournier-Lasserve E, Levade T, Boespflug Tanguy O, Labauge P.

Brain. 2015 Feb;138(Pt 2):284-92. doi: 10.1093/brain/awu353. Epub 2014 Dec 19.

PMID:
25527826
34.

Relevance of corpus callosum splenium versus middle cerebellar peduncle hyperintensity for FXTAS diagnosis in clinical practice.

Renaud M, Perriard J, Coudray S, Sévin-Allouet M, Marcel C, Meissner WG, Chanson JB, Collongues N, Philippi N, Gebus O, Quenardelle V, Castrioto A, Krack P, N'Guyen K, Lefebvre F, Echaniz-Laguna A, Azulay JP, Meyer N, Labauge P, Tranchant C, Anheim M.

J Neurol. 2015 Feb;262(2):435-42. doi: 10.1007/s00415-014-7557-7. Epub 2014 Dec 2.

PMID:
25451852
35.

Chronic Bickerstaff's encephalitis with cognitive impairment, a reality?

Renaud M, Aupy J, Camuset G, Collongues N, Chanson JB, de Seze J, Blanc F.

BMC Neurol. 2014 May 6;14:99. doi: 10.1186/1471-2377-14-99.

36.

[Cerebrotendinous xanthomatosis: a multicentric retrospective study of 15 adults, clinical and paraclinical typical and atypical aspects].

Lionnet C, Carra C, Ayrignac X, Levade T, Gayraud D, Castelnovo G, Besson G, Androdias G, Vukusic S, Confavreux C, Zaenker C, De Seze J, Collongues N, Blanc F, Tranchant C, Wallon D, Hannequin D, Gerdelat-Mas A, Brassat D, Clanet M, Zephir H, Outteryck O, Vermersch P, Labauge P.

Rev Neurol (Paris). 2014 Jun-Jul;170(6-7):445-53. doi: 10.1016/j.neurol.2014.01.675. Epub 2014 Apr 16. French.

PMID:
24746394
37.

Isolated anti-β2-glycoprotein I antibodies in neurology: a frontier syndrome between multiple sclerosis and antiphospholipid syndrome?

Renaud M, Aupy J, Uring-Lambert B, Chanson JB, Collongues N, Blanc F, De Sèze J.

Eur J Neurol. 2014 Jun;21(6):901-6. doi: 10.1111/ene.12408. Epub 2014 Apr 2.

PMID:
24698178
38.

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.

Collongues N, Marignier R, Jacob A, Leite MI, Siva A, Paul F, Zephir H, Akman-Demir G, Elsone L, Jarius S, Papeix C, Mutch K, Saip S, Wildemann B, Kitley J, Karabudak R, Aktas O, Kuscu D, Altintas A, Palace J, Confavreux C, De Seze J.

Mult Scler. 2014 Jul;20(8):1086-94. doi: 10.1177/1352458513515085. Epub 2013 Dec 9.

PMID:
24323817
39.

[A first seizure revealing Sneddon's syndrome].

Quenardelle V, Willaume T, Benoilid A, Collongues N, De Seze J.

Rev Neurol (Paris). 2014 Jan;170(1):55-7. doi: 10.1016/j.neurol.2013.04.011. Epub 2013 Nov 26. French. No abstract available.

PMID:
24290846
40.

[Nosology and etiologies of acute longitudinally extensive transverse myelitis].

Collongues N, Papeix C, Zéphir H, Audoin B, Cotton F, Durand-Dubief F, Vukusic S, Brassat D, Laplaud D, Marignier R; Groupe Nomadmus.

Rev Neurol (Paris). 2014 Jan;170(1):6-12. doi: 10.1016/j.neurol.2013.04.008. Epub 2013 Nov 21. French.

PMID:
24269116
41.

Cognitive Dysfunction and Dementia in Primary Sjögren's Syndrome.

Blanc F, Longato N, Jung B, Kleitz C, Di Bitonto L, Cretin B, Collongues N, Sordet C, Fleury M, Poindron V, Gottenberg JE, Anne O, Lipsker D, Martin T, Sibilia J, de Seze J.

ISRN Neurol. 2013 Sep 19;2013:501327. doi: 10.1155/2013/501327. eCollection 2013.

42.

Relapsing optic neuritis: a multicentre study of 62 patients.

Benoilid A, Tilikete C, Collongues N, Arndt C, Vighetto A, Vignal C, de Seze J.

Mult Scler. 2014 Jun;20(7):848-53. doi: 10.1177/1352458513510223. Epub 2013 Oct 31.

PMID:
24177207
43.

Novel advances in the diagnosis and treatment of neuromyelitis optica: is there a need to redefine the gold standard?

de Seze J, Collongues N.

Expert Rev Clin Immunol. 2013 Oct;9(10):979-86. doi: 10.1586/1744666X.2013.839944. Review.

PMID:
24128159
44.

Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients.

Kremer L, Mealy M, Jacob A, Nakashima I, Cabre P, Bigi S, Paul F, Jarius S, Aktas O, Elsone L, Mutch K, Levy M, Takai Y, Collongues N, Banwell B, Fujihara K, de Seze J.

Mult Scler. 2014 Jun;20(7):843-7. doi: 10.1177/1352458513507822. Epub 2013 Oct 7.

PMID:
24099751
45.

JC-virus seroconversion in multiple sclerosis patients receiving natalizumab.

Outteryck O, Zéphir H, Salleron J, Ongagna JC, Etxeberria A, Collongues N, Lacour A, Fleury MC, Blanc F, Giroux M, de Seze J, Vermersch P.

Mult Scler. 2014 Jun;20(7):822-9. doi: 10.1177/1352458513505353. Epub 2013 Sep 26.

PMID:
24072722
46.

Reduction of the washout time between natalizumab and fingolimod.

de Seze J, Ongagna JC, Collongues N, Zaenker C, Courtois S, Fleury M, Benoilid A, Chanson JB, Blanc F; Alsacep Network.

Mult Scler. 2013 Aug;19(9):1248. doi: 10.1177/1352458513490551. Epub 2013 May 30. No abstract available.

PMID:
23722322
47.

Evaluation of clinical interest of anti-aquaporin-4 autoantibody followup in neuromyelitis optica.

Chanson JB, Alame M, Collongues N, Blanc F, Fleury M, Rudolf G, de Seze J, Vincent T.

Clin Dev Immunol. 2013;2013:146219. doi: 10.1155/2013/146219. Epub 2013 Apr 28.

48.

A case of recurrent facial pain associated with a Pourfour du Petit syndrome: a new entity?

Collongues N, Labouret P, Speeg C, de Seze J.

Headache. 2014 Feb;54(2):373-7. doi: 10.1111/head.12137. Epub 2013 May 23.

PMID:
23700978
49.

Aquaporin-4 antibody-negative neuromyelitis optica: distinct assay sensitivity-dependent entity.

Marignier R, Bernard-Valnet R, Giraudon P, Collongues N, Papeix C, Zéphir H, Cavillon G, Rogemond V, Casey R, Frangoulis B, De Sèze J, Vukusic S, Honnorat J, Confavreux C; NOMADMUS Study Group.

Neurology. 2013 Jun 11;80(24):2194-200. doi: 10.1212/WNL.0b013e318296e917. Epub 2013 May 8.

PMID:
23658379
50.

Longitudinal follow-up of vision in a neuromyelitis optica cohort.

Bouyon M, Collongues N, Zéphir H, Ballonzoli L, Jeanjean L, Lebrun C, Chanson J, Blanc F, Fleury M, Outteryck O, Defoort S, Labauge P, Vermersch P, Speeg C, De Seze J.

Mult Scler. 2013 Sep;19(10):1320-2. doi: 10.1177/1352458513476562. Epub 2013 Feb 14.

PMID:
23413296

Supplemental Content

Loading ...
Support Center